Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit
The license is valid for five years, effective from April 9, 2026
The license is valid for five years, effective from April 9, 2026
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
If approved, imlifidase has the potential to transform the kidney transplant landscape by enabling highly sensitized patients to also have access to a potentially life-changing kidney transplant
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
The complex four-hour surgery was performed by a multidisciplinary team of doctors
Separate Phase 3 study evaluating 200 days of therapy with PREVYMIS in HSCT recipients at high risk of late clinically significant CMV infection recently completed, meeting its primary endpoint
The hospital works in close collaboration with the Network for Organ Sharing and the National Organ & Tissue Transplant Organisation (NOTTO) and it is amongst the very few hospitals doing ABO-incompatible transplant
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
Subscribe To Our Newsletter & Stay Updated